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S U M M A R Y
Objectives: The aim of this study was to investigate the molecular epidemiology and clinical
characteristics of a major clone of oxacillin-resistant Staphylococcus lugdunensis in a tertiary hospital.
Methods: All S. lugdunensis isolated from sterile sites between June 2003 and May 2013 were collected
for analysis. Pulsed-ﬁeld gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were
performed to study their genetic relationships.
Results: A total of 118 S. lugdunensis isolates were analysed by PFGE. Three major PFGE pulsotypes were
found: A, H, and L. Most of the pulsotype A isolates were oxacillin-resistant, and SCCmec type V and type
VT. Isolates from another major clonal group that consisted primarily of pulsotype L were oxacillin-
resistant and SCCmec type II. These 14 SCCmec type II S. lugdunensis isolates demonstrated high PFGE
similarity and were obtained in the study hospital over a period of 40 months. Three of these 14 patients
had clinically signiﬁcant bacteraemia, and all three cases were in the intensive care unit. Further MLST
analysis of the isolates identiﬁed an endemic S. lugdunensis strain of sequence type 6, clonal complex 1.
Conclusions: This study identiﬁed a major endemic clone of S. lugdunensis that is oxacillin-resistant,
SCCmec type II, ST6, and capable of long-term persistence in the hospital. Continuous infection control
surveillance and monitoring of S. lugdunensis should be considered in endemic areas.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Coagulase-negative staphylococci (CoNS), once regarded as
harmless inhabitants of the skin and mucosal lining, have emerged
as important nosocomial pathogens,1,2 the main cause of catheter-
related infections among immunosuppressed or neutropenic
patients,3,4 and a major cause of nosocomial infection in the
neonatal intensive care unit (ICU).5–7 The predominant CoNS
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).epidermidis, followed by Staphylococcus haemolyticus and Staphy-
lococcus hominis.8,9 In contrast to other CoNS, Staphylococcus
lugdunensis behaves more like Staphylococcus aureus. It is
responsible for a wide spectrum of infections, including skin
and soft tissue infections, bone and joint infections, meningitis,
catheter-related infections, bacteraemia, and infective endocardi-
tis.10 Higher mortality rates have been reported for endocarditis
associated with S. lugdunensis than with S. aureus or S. epidermi-
dis.10 A previous study of 48 patients with invasive S. lugdunensis
infections (including 41 bacteraemia cases) seen at Chang Gung
Memorial Hospital at Linkou (CGMH-Linkou) between 2002 and
2012 revealed that the majority of cases (43/48, 89.6%) were
healthcare-associated or hospital-acquired infections.11 Ten of the
48 S. lugdunensis isolates were oxacillin-resistant and were either
healthcare-associated or hospital-acquired. Researchers have
previously documented the clonal spread of CoNS within hospitalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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CoNS.12,13 However, only a limited number of studies have
investigated S. lugdunensis clonality in the hospital environment,
its antimicrobial susceptibility, and clinical outcomes.
The aim of this study was to investigate the molecular
epidemiology of oxacillin-resistant S. lugdunensis in order to
detect the possible spread of speciﬁc S. lugdunensis clones in the
hospital environment throughout the study period.
2. Methods
2.1. Study design, study site, and study population
This retrospective study was conducted at CGMH-Linkou, a
3715-bed tertiary centre in northern Taiwan. The study was
approved by the Research Ethics Committee of CGMH-Linkou
(103-2786B).
Between June 2003 and May 2013, a total of 118 S. lugdunensis
isolates were collected from sterile sites (blood, ascites, pleural
effusion, synovial ﬂuid, cerebrospinal ﬂuid, and amniotic ﬂuid);
these were identiﬁed using the computer-assisted microbiology
laboratory database.
Patients for whom S. lugdunensis was isolated from two or more
consecutive blood cultures or sterile body ﬂuids were considered
clinically signiﬁcant cases. For cases with a single positive blood
culture of S. lugdunensis, clinical signiﬁcance was determined
according to the criteria developed by Souvenir et al. in 1998.14
Patient cases were considered clinically signiﬁcant if they
presented one or more of the following symptoms: fever
(temperature >38 8C), hypotension (systolic blood pressure
<90 mmHg), leukocytosis or leukopenia with a left-shifted
differential, and disseminated intravascular coagulopathy. In
addition they had to present a major risk factor for potential
infection caused by the skin ﬂora, including long-term intravascu-
lar catheterization, which is used for patients in critical care units,
immunosuppressed patients with central lines, and those under-
going peritoneal dialysis or haemodialysis.
Patient data, including demographic characteristics, comorbid-
ities, origin of infection, sources of infection, treatments, and
outcomes, were collected by chart review. Bacteraemia without an
identiﬁed infection source was deﬁned as primary bacteraemia. An
infection that occurred more than 48 h after hospitalization was
classiﬁed as a hospital-acquired infection. The date and the site
(department and hospital bed) of each S. lugdunensis isolation were
also analysed to investigate potential clusters or nosocomial
outbreaks during this period.
2.2. Bacterial isolates and antimicrobial susceptibility testing
The BACTEC 9240 system (Becton, Dickinson and Company,
Madison, WI, USA) was used to process blood cultures, ascites, and
synovial ﬂuid. Other sterile body ﬂuids were processed using
conventional methods. Isolates were initially identiﬁed as S.
lugdunensis according to the following properties: aerobic, Gram-
positive cocci in clusters, catalase-positive, coagulase-negative,
pyrrolidonyl arylamidase test (PYR test)-positive, and positive for
ornithine decarboxylase activity.15 PCR and the Bruker Biotyper
(database 2.0) matrix-assisted laser desorption/ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS) method were used to
conﬁrm the organism as S. lugdunensis.16,17 The minimal inhibitory
concentration (MIC) for oxacillin was determined using the agar
dilution method in accordance with the Clinical and Laboratory
Standards Institute (CLSI, Wayne, PA, USA) guidelines;18 the
susceptibility testing of other antimicrobials (clindamycin, eryth-
romycin, etc.) was performed using the CLSI disc diffusion
method.182.3. SCCmec typing
Staphylococcal cassette chromosome mec (SCCmec) gene typing
for oxacillin-resistant S. lugdunensis was determined using a
combination of multiplex PCRs, as described previously by Kondo
et al.19
2.4. Pulsed-ﬁeld gel electrophoresis
All oxacillin-resistant S. lugdunensis were typed by pulsed-ﬁeld
gel electrophoresis (PFGE) as described previously.20 After
electrophoresis, the gel was stained in 1.5 mg/ml ethidium
bromide solution (Amresco Inc., Solon, OH, USA) for 20 min in a
covered container and then destained in fresh distilled water for
45 min. The gels were then photographed and digitized with the
FOTO/Analyst Archiver System (Fotodyne Inc., Hartland, WI, USA)
and saved as TIFF ﬁles for analysis with BioNumerics software 6.0
(Applied Maths Inc., Austin, TX, USA). Percentage similarities were
identiﬁed on a dendrogram derived from the unweighted pair
group method using arithmetic averages and based on Dice
coefﬁcients. Band position tolerance and optimization were set at
1.25 and 0.5%, respectively. A similarity coefﬁcient of 80% was
selected to deﬁne closely related strains (clone).
2.5. Multilocus sequence typing
The multilocus sequence typing (MLST) scheme developed by
Chassain et al. was used to study the genetic relationship and
population structure of S. lugdunensis isolates.21 Seven housekeep-
ing loci were selected for the characterization of S. lugdunensis
isolates by MLST: aroE (shikimate dehydrogenase), dat (D-amino
acid aminotransferase), ddl (D-alanine:D-alanine ligase), gmk
(guanylate kinase), ldh (L-lactate dehydrogenase), recA (recombi-
nase), and yqiL (acetyl-coenzyme A acetyltransferase). Different
sequences of a given locus were given allele numbers, and each
unique combination of alleles (multilocus allelic proﬁle) was
assigned a sequence type (ST).
3. Results
A total of 118 S. lugdunensis strains isolated from blood (n = 105)
or sterile site ﬂuids (n = 13) were examined during the study
period. All isolates were susceptible to vancomycin and teicopla-
nin, and 42 of them (35.6%) were resistant to oxacillin. All
42 oxacillin-resistant S. lugdunensis isolates carried the mecA gene;
a little over half (23/42, 54.8%) were SCCmec type V, followed by
type II (14/42, 33.3%), type VT (3/42, 7.1%), and type IV (2/42, 4.8%).
Figure 1 depicts the PFGE pattern for all 118 isolates. Three major
PFGE pulsotypes were found: A (27 isolates), H (30 isolates), and L
(13 isolates); these accounted for 59.3% (70/118) of all isolates.
Most of the pulsotype A isolates were oxacillin-resistant, SCCmec
type V (19 isolates), and type VT (three isolates). Another major clone
of oxacillin-resistant isolates were SCCmec type II and primarily
pulsotype L. Most pulsotype H isolates were susceptible to oxacillin.
The genetic relationship between the C25 isolate, an SCCmec type V S.
lugdunensis strain (SL25) from the China Medical University Hospital
in central Taiwan,22 and isolates from the present study was also
analysed. It was found that C25 has a high degree of genetic similarity
(84.2%) to the pulsotype A isolates in the present study.
Of the 23 SCCmec type V isolates, 10 were clinical infectious
cases. Seven of these (7/10, 70%) were hospital-acquired infections.
Primary bacteraemia (four cases) and catheter-related infection
(two cases) accounted for most of the infectious sources in
hospital-acquired infections. Skin and soft tissue infection (two
cases) and peritonitis (one case) were two primary infectious
sources in community-acquired infection.
Figure 1. Pulsed-ﬁeld gel electrophoresis of 118 Staphylococcus lugdunensis isolates (SL 1–118); groups are designated A–AF. (A) First part. (B) Second part. SL, Staphylococcus
lugdunensis; S, susceptible; R, resistant; ST, sequence type; CC, clonal complex. *C25: the SCCmec type V strain (SL 25) from China Medical University Hospital. **Non-typeable.
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the 14 SCCmec type II isolates, each with several 100% identical
PFGE isolates. All 14 isolates were highly resistant to oxacillin (MIC
>32 mg/ml) and were resistant to both clindamycin and erythro-
mycin. This major clone of S. lugdunensis was ﬁrst isolated in the
study hospital in September 2009 and persisted until January 2013,
a period of about 40 months. Eight isolates from the 14 SCCmec
type II S. lugdunensis strains were selected for MLST analysis:
SL27(L2), SL28(M1), SL43(L1), SL44(L4), SL75(L1), SL95(L3),SL110(H2), and SL118(M2). These eight isolates contained at least
one isolate from each subgroup of the PFGE proﬁle analysis. The
allelic proﬁles of the eight isolates were the same (aroE: 1; dat: 1;
ddl: 1; gmk: 1; ldh: 1; recA: 1; yqiL: 2), indicating that all were ST6,
clonal complex (CC) 1.21
The demographic data and clinical characteristics of these
14 bacteraemia cases are reviewed in Table 1. Three of the
14 bacteraemia episodes were recognized as clinically signiﬁcant
infections, all of which were hospital-acquired primary
Fig. . (Continued ).
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two patients were 10-month-old infants. These three patients
acquired infections in the ICU after a long hospital stay (18, 94, and
309 days, respectively). All received adequate antimicrobial
therapy (vancomycin or teicoplanin), but the adult patient died
of sepsis-related multiple organ failure on day 28 of S. lugdunensis
bacteraemia.
Further analysis of the date, department, and ward of isolation
for each of the 14 SCCmec type II, ST6 S. lugdunensis isolates is
depicted in Figure 2. Most isolates (10/14) were obtained from the
emergency department (ER), three were from the ICU, and one was
from the general medicine ward. Two isolates in pulsotype L3 with
a 100% identical PFGE pattern were obtained from the same
paediatric intensive care unit (PICU) over an 18-day interval, with
both isolates causing clinically signiﬁcant infections.4. Discussion
Most studies in the literature have described a clonal spreading
or nosocomial outbreak of CoNS other than S. lugdunensis.13,23–26
This molecular epidemiology study revealed two major clones of
oxacillin-resistant S. lugdunensis. The SCCmec type V isolates
identiﬁed in this study had a high degree of genetic similarity to an
SCCmec type V isolate from the China Medical University Hospital
in central Taiwan. Yen et al. reported that most of their SCCmec
type V isolates (four of ﬁve cases) were from community-acquired
infections.22 The existence of a major endemic clone of oxacillin-
resistant, SCCmec type II, ST6 S. lugdunensis, which has not yet been
reported in Taiwan or elsewhere, was of interest. This major clone
was isolated continuously from different patients and different
hospital wards over a 40-month period, indicating that this major
Table 1
Antimicrobial susceptibility and general data for 14 patients with oxacillin-resistant Staphylococcus lugdunensis SCCmec type II isolates
Strain Pulsotype Age
(years)/
sex
Date of SL
isolation
LOS (days) until
SL bacteraemia
Ward Oxacillin
MIC (mg/ml)
Clindamycin
susceptibility
Erythromycin
susceptibility
Infection
source
Treatment
regimen
30-day
outcome
SL81 M3 2/F 2011.11.27 1 ER >32 R R - - -
SL28 M1 72/M 2010.02.18 10 GM >32 R R - - -
SL118 M2 0.4/F 2012.08.13 2 ER >32 R R - - -
SL110 H2 84/F 2012.12.22 1 ER >32 R R - - -
SL75 L1 34/M 2011.09.08 1 ER >32 R R - - -
SL109 L1 58/M 2012.12.21 1 ER >32 R R - - -
SL18 L1 5/M 2009.09.19 1 ER >32 R R - - -
SL43 L1 78/M 2010.08.23 1 ER >32 R R - - -
SL27 L2 0.2/M 2010.02.15 1 ER >32 R R - - -
SL114 L4 79/F 2012.08.16 1 ER >32 R R - - -
SL44 L4 55/F 2010.08.25 18 EICU >32 R R Primary
bacteraemia
Teicoplanin
4 weeks
Died
SL67 L4 56/F 2011.04.27 1 ER >32 R R - - -
SL95 L3 0.8/M 2013.01.14 94 PICU >32 R R Primary
bacteraemia
Teicoplanin
2 weeks
Survived
SL112 L3 0.8/F 2012.12.27 309 PICU >32 R R Primary
bacteraemia
Vancomycin
4 weeks
Survived
EICU, emergency department intensive care unit; ER, emergency department; F, female; GM, general medicine ward; LOS, length of stay; M, male; MIC, minimal inhibitory
concentration; PICU, paediatric intensive care unit; R, resistant; SL, Staphylococcus lugdunensis.
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existence, persistence, and spread of oxacillin-resistant CoNS with
endemic clones within the hospital environment has been
described in Brazil and Greece.27,28 The present study is the ﬁrst
report of a major clone of oxacillin-resistant S. lugdunensis
circulating within a hospital. The clone identity was conﬁrmed
by both PFGE and MLST analysis.
In the present study, there were three major subgroups (L1, L3,
and L4) of isolates, each with 100% PFGE similarity. Four strains of
pulsotype L1 were obtained from patients in the ER for more than
3 years. Three pulsotype L4 isolates were distributed across
different wards, and one patient in the emergency ICU (EICU) had a
clinically signiﬁcant infection. Two isolates of pulsotype L3 wereFigure 2. The date and department for all 14 methicillin-resistant Staphylococcus lugdu
paediatric intensive care unit; EICU, emergency department intensive care unit; GM, gisolated in the PICU only 18 days apart and were obtained from two
neonates with clinically signiﬁcant bacteraemia. Ten of our
14 cases from the ER were admitted shortly before presenting
with bacteraemia. It was difﬁcult to determine whether these
isolates represented a hospital or community origin of infection
due to the retrospective study design. However, the other four
isolates from the ward or ICU were isolated after a long hospital
stay, strongly indicating a hospital-acquired isolate. Further
investigation is needed to determine whether the hospital isolate
originated from the community or the hospital environment.
Three of the 14 patients had clinically signiﬁcant bacteraemia.
All were in the ICU when the bacteraemia occurred, and two were
neonates with a prolonged ICU stay prior to infection. These resultsnensis SCCmec II isolated during the study period. E, emergency department; PICU,
eneral medicine ward.
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are vulnerable to S. lugdunensis infection. CoNS are a major cause of
nosocomial infection, especially in ICU patients, neonates,
immunocompromised hosts, and patients with central venous
catheters.2,4–7 CoNS infections are associated with an increase in
morbidity and have a directly attributable mortality rate as high as
14%.29 However, the mortality rate of S. lugdunensis bacteraemia is
usually higher than that of other CoNS; a mortality rate of 28.6%
was observed in a recent study,11 and mortality rates of 0–23%
have been reported previously.30–32
Despite the importance of CoNS as a cause of hospital-acquired
infection, limited information is available regarding the reservoir,
distribution, and mode of transmission within the hospital
environment. Recent studies using new molecular typing methods,
such as PFGE, suggest that the clonal spread of CoNS may occur
within and between hospital wards.23 However, the present
retrospective study lacks an analysis of S. lugdunensis colonization
in the hospital environment and healthcare workers.
Chassain et al. developed an MLST scheme for the analysis of S.
lugdunensis genetic relationships.21 Within the total 87 isolates in
their study, 20 different STs and ﬁve CCs were represented. Four
major STs belonging to CC1 contained isolates that were mostly
from France and Belgium. The present work provides important
epidemiological information on S. lugdunensis outside Europe.
More clinical and sequencing data should be obtained worldwide
to help elucidate the global epidemiology and evolution. This ﬁrst
phylogenetic analysis of S. lugdunensis in Taiwan provides
important information on the hospital epidemiology and infection
control, surveillance, and monitoring.
This is the ﬁrst study demonstrating the long-term persistence
of an endemic clone of S. lugdunensis responsible for nosocomial
infections within a hospital. S. lugdunensis has been recognized as a
major pathogenic species within the CoNS. It is suggested that
further investigations be performed to elucidate its mode of
transmission and the S. lugdunensis reservoir, and to identify
speciﬁc preventive measures that could minimize the emergence
and spread of such bacteria in the hospital environment, especially
in the ICU.
Financial support: This work was supported by grants from
Chang Gung Memorial Hospital (CMRPG3B0642) and the Ministry
of Science and Technology of the Republic of China (Taiwan) (NSC-
101-2320-B-182A-002-MY3).
Conﬂict of interest: All authors declare no potential conﬂicts of
interests.
References
1. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al.
Antimicrobial-resistant pathogens associated with healthcare-associated infec-
tions: summary of data reported to the National Healthcare Safety Network at
the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp
Epidemiol 2013;34:1–14.
2. Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance proﬁles of
bacterial strains isolated from patients with hospital-acquired bloodstream and
urinary tract infections. Crit Care Res Pract 2012. http://dx.doi.org/10.1155/
2012/890797.
3. Van Pelt C, Nouwen J, Lugtenburg E, Van der Schee C, de Marie S, Schuijff P, et al.
Strict infection control measures do not prevent clonal spread of coagulase
negative staphylococci colonizing central venous catheters in neutropenic
hemato-oncologic patients. FEMS Immunol Med Microbiol 2003;38:153–8.
4. Viale P, Stefani S. Vascular catheter-associated infections: a microbiological and
therapeutic update. J Chemother 2006;18:235–49.
5. Mitt P, Metsvaht T, Adamson V, Telling K, Naaber P, Lutsar I, et al. Five-year
prospective surveillance of nosocomial bloodstream infections in an Estonian
paediatric intensive care unit. J Hosp Infect 2014;86:95–9.
6. Pires Pereira CA, Marra AR, Aranha Camargo LF, Campos Pignatari AC, Sukiennik
T, Petersen Behar PR, et al. Nosocomial bloodstream infections in Brazilian
paediatric patients: microbiology, epidemiology, and clinical features. PLoS One
2013;8:e68144.
7. Hall SL. Coagulase-negative staphylococcal infections in neonates. Pediatr Infect
Dis J 1991;10:57–67.8. Molina J, Penˇuela I, Lepe JA, Gutie´rrez-Pizarraya A, Go´mez MJ, Garcia-Cabrera E,
et al. Mortality and hospital stay related to coagulase negative staphylococci
bacteraemia in non-critical patients. J Infect 2013;66:155–62.
9. Ferna´ndez-Rufete A, Garcı´a-Va´zquez E, Herna´ndez-Torres A, Canteras M, Ruiz J,
Go´mez J. Coagulase-negative Staphylococcus bacteraemia: prognosis factors
and inﬂuence of antibiotic treatment. Rev Esp Quimioter 2012;25:199–205.
10. Frank KL, del Pozo JL, Patel R. From clinical microbiology to infection patho-
genesis: how daring to be different works for Staphylococcus lugdunensis. Clin
Microbiol Rev 2008;21:111–33.
11. Lin JF, Cheng CW, Kuo AJ, Liu TP, Yang CC, Huang CT, et al. Clinical experience
and microbiologic characteristics of invasive Staphylococcus lugdunensis infec-
tion in a tertiary center in northern Taiwan. J Microbiol Immunol Infect 2014.
http://dx.doi.org/10.1016/j.jmii.2013.12.010. In Press Corrected Proof, Pub-
lished on line.
12. Monsen T, Olofsson C, Ro¨nnmark M, Wistro¨m J. Clonal spread of staphylococci
among patients with peritonitis associated with continuous ambulatory peri-
toneal dialysis. Kidney Int 2000;57:613–8.
13. Monsen T, Karlsson C, Wistro¨m J. Spread of clones of multidrug-resistant,
coagulase-negative staphylococci within a university hospital. Infect Control
Hosp Epidemiol 2005;26:76–80.
14. Souvenir D, Anderson Jr DE, Palpant S, Mroch H, Askin S, Anderson J, et al. Blood
cultures positive for coagulase negative staphylococci: antisepsis, pseudobac-
teraemia, and therapy of patients. J Clin Microbiol 1998;36:1923–6.
15. Bannerman TL, Peacock SJ. Staphylococcus, Micrococcus, and other catalase-
positive cocci. In: Murray PR, Baron EJ, editors. Manual of clinical microbiology.
9th ed., Washington, DC: American Society of Microbiology Press; 2007. p. 390–
411.
16. Noguchi N, Goto K, Ro T, Narui K, Ko M, Nasu Y, et al. Using the tannase gene to
rapidly and simply identify Staphylococcus lugdunensis. Diagn Microbiol Infect
Dis 2010;66:120–3.
17. Szabados F, Woloszyn J, Richter C, Kaase M, Gatermann S. Identiﬁcation of
molecularly deﬁned Staphylococcus aureus strains using matrix-assisted
laser desorption/ionization time of ﬂight mass spectrometry and the Biotyper
2.0 database. J Med Microbiol 2010;59:787–90.
18. Clinical and Laboratory Standards Institute. Performance standards for antimi-
crobial susceptibility testing; twenty-fourth informational supplement. CLSI
document M100-S24. Wayne, PA: CLSI; 2014.
19. Kondo Y, Ito T, Ma XX, Watanabe S, Kreiswirth BN, Etienne J, et al. Combination
of multiplex PCRs for staphylococcal cassette chromosome mec type assign-
ment: rapid identiﬁcation system for mec, ccr, and major differences in
junkyard regions. Antimicrob Agents Chemother 2007;51:264–74.
20. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC.
Pulse-ﬁeld gel electrophoresis typing of oxacillin-resistant Staphylococcus
aureus isolates from the United States: establishing a national database. J Clin
Microbiol 2003;11:5113–20.
21. Chassain B, Leme´e L, Didi J, Thiberge JM, Brisse S, Pons JL, et al. Multilocus
sequence typing analysis of Staphylococcus lugdunensis implies a clonal popu-
lation structure. J Clin Microbiol 2012;50:3003–9.
22. Yen TY, Sung YJ, Lin HC, Peng CT, Tien N, Hwang KP, et al. Emergence of
oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette
chromosome mec type V in central Taiwan. J Microbiol Immunol Infect 2014.
http://dx.doi.org/10.1016/j.jmii.2014.11.018. In Press Corrected Proof, Pub-
lished on line.
23. Muldrew KL, Tang YW, Li H, Stratton CW. Clonal dissemination of Staphylococ-
cus epidermidis in an oncology ward. J Clin Microbiol 2008;46:3391–6.
24. Liakopoulos V, Petinaki E, Efthimiadi G, Klapsa D, Giannopoulou M, Dovas S,
et al. Clonal relatedness of oxacillin-resistant coagulase-negative staphylococci
in the haemodialysis unit of a single university centre in Greece. Nephrol Dial
Transplant 2008;23:2599–603.
25. Foka A, Chini V, Petinaki E, Kolonitsiou F, Anastassiou ED, Dimitracopoulos G,
et al. Clonality of slime-producing oxacillin resistant coagulase-negative staph-
ylococci disseminated in the neonatal intensive care unit of a university
hospital. Clin Microbiol Infect 2006;12:1230–3.
26. Widerstro¨m M, Monsen T, Karlsson C, Wistro¨m J. Molecular epidemiology of
meticillin-resistant coagulase-negative staphylococci in a Swedish county
hospital: evidence of intra- and interhospital clonal spread. J Hosp Infect
2006;64:177–83.
27. Martins A, Riboli DF, Camargo CH, Pereira VC, de Almeida Sampaio R, de Souza
da Cunha Mde L. Antimicrobial resistance and persistence of Staphylococcus
epidermidis clones in a Brazilian university hospital. Diagn Microbiol Infect Dis
2013;77:164–8.
28. Spiliopoulou I, Santos Sanches I, Bartzavali C, Ludovice AM, Aires de Sousa M,
Dimitracopoulos G, et al. Application of molecular typing methods to characterize
nosocomial coagulase-negative staphylococci collected in a Greek hospital during
a three-year period (1998–2000). Microb Drug Resist 2003;9:273–82.
29. Martin MA, Pfaller MA, Wenzel RP. Coagulase negative staphylococcal bacter-
aemia: mortality and hospital stay. Ann Intern Med 1989;110:9–16.
30. Zinkernagel AS, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, Zbinden R, et al.
Signiﬁcance of Staphylococcus lugdunensis bacteremia: report of 28 cases and
review of the literature. Infection 2008;36:314–21.
31. Choi SH, Chung JW, Lee EJ, Kim TH, Lee MS, Kang JM, et al. Incidence, char-
acteristics, and outcomes of Staphylococcus lugdunensis bacteraemia. J Clin
Microbiol 2010;48:3346–9.
32. Ebright JR, Penugonda M, Brown W. Clinical experience with Staphylococcus
lugdunensis bacteraemia: a retrospective analysis. Diagn Microbiol Infect Dis
2004;48:17–21.
